Five-year results of patients supported by HeartMate II: Outcomes and adverse events
European Journal of Cardio-Thoracic Surgery Sep 08, 2017
Hanke JS, et al. - Authors in this single-centre cohort study reported 5-year outcomes with the HeartMate II (HMII) left ventricular assist device (LVAD). Findings revealed a 5-year survival of 54% in this single-centre cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
